We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+23.01%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$900M
Cap. Flow
+$775M
Cap. Flow %
39.93%
Top 10 Hldgs %
51.62%
Holding
194
New
73
Increased
41
Reduced
31
Closed
42

Top Buys

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$24.5M
2
PPD
PPD, Inc. Common Stock
PPD
+$19M
3
OM icon
Outset Medical
OM
+$18.6M
4
AFIB
Acutus Medical Inc
AFIB
+$16.2M
5
VCEL icon
Vericel Corp
VCEL
+$14.9M

Top Sells

Rank Stock Value
1
LHCG
LHC Group LLC
LHCG
+$8.66M
2
INSP icon
Inspire Medical Systems
INSP
+$8.51M
3
LIVN icon
LivaNova
LIVN
+$7.29M
4
OSUR icon
OraSure Technologies
OSUR
+$6.64M
5
BSX icon
Boston Scientific
BSX
+$6.44M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Industrials 0.76%
3 Consumer Staples 0.45%
4 Energy 0.25%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EOLS icon
126
PUT
Evolus
EOLS
$536M
$1.15M 0.06%
294,500
+212,600
+260% +$777K
OBIO icon
127
Orchestra BioMed
OBIO
$266M
$1.1M 0.06%
+100,000
New +$1.12M
TMDX icon
128
PUT
Transmedics
TMDX
$3.02B
$1.03M 0.05%
+75,000
New +$1.28M
TPB icon
129
Turning Point Brands
TPB
$1.73B
$927K 0.05%
+33,238
New +$977K
GNLN icon
130
Greenlane Holdings
GNLN
$1.19M
– –
0
– –
CRBP icon
131
PUT
Corbus Pharmaceuticals
CRBP
$189M
$900K 0.05%
+16,667
New +$3.02M
CRBP icon
132
Corbus Pharmaceuticals
CRBP
$189M
$879K 0.05%
+16,273
New +$2.95M
AGTC
133
DELISTED
Applied Genetic Technologies Corporation
AGTC
$857K 0.04%
176,411
-15,488
-8% -$84.6K
EOLS icon
134
CALL
Evolus
EOLS
$536M
$782K 0.04%
200,000
+69,000
+53% +$252K
BMRN icon
135
BioMarin Pharmaceuticals
BMRN
$13.6B
$761K 0.04%
+10,000
New +$1.01M
AUPH icon
136
Aurinia Pharmaceuticals
AUPH
$2.06B
$737K 0.04%
+50,000
New +$724K
MIST icon
137
Milestone Pharmaceuticals
MIST
$141M
$732K 0.04%
+100,000
New +$717K
CODX
138
PUT
Co-Diagnostics
CODX
$5.45M
$680K 0.04%
+1,667
New +$856K
FLNA
139
CALL
Filana Therapeutics
FLNA
$45.1M
$576K 0.03%
+50,000
New +$225K
LQDA icon
140
Liquidia Corp
LQDA
$7.01B
$492K 0.03%
100,000
-50,000
-33% -$289K
BCRX icon
141
PUT
BioCryst Pharmaceuticals
BCRX
$2.71B
$401K 0.02%
+116,800
New +$501K
SVRA icon
142
Savara
SVRA
$1.17B
$291K 0.02%
266,570
-82,198
-24% -$141K
PAND
143
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$287K 0.01%
+25,000
New +$427K
CRIS icon
144
Curis
CRIS
$3.49M
$234K 0.01%
+500
New +$236K
TSHA icon
145
Taysha Gene Therapies
TSHA
$2.05B
$224K 0.01%
+10,000
New +$235K
SRRA
146
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$202K 0.01%
18,940
– –
PRLD icon
147
Prelude Therapeutics
PRLD
$456M
$151K 0.01%
+5,000
New +$141K
EPIX
148
DELISTED
ESSA Pharma
EPIX
$138K 0.01%
+20,000
New +$136K
MAPSW
149
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$31K ﹤0.01%
50,000
– –
OTIC
150
CALL
DELISTED
Otonomy, Inc.
OTIC
$3K ﹤0.01%
+800
New +$3.02K
4 5
6
7 8

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2020 Portfolio in Review

As of Q3 2020, Pura Vida Investments held 194 positions worth $1.94B, up 87% from $1.04B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pura Vida Investments deployed $775M of net new capital in Q3 2020, opening 73 new positions and adding to 41 existing holdings. Its largest new stake was Cooper Companies: 320,000 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was LHC Group LLC, an estimated $8.66M trimmed.

  • Pura Vida Investments's largest Q3 2020 buy was Cooper Companies: 320,000 shares worth $27M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q3 2020, an estimated $11.6M increase.
  • Pura Vida Investments's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $8.66M.
  • Pura Vida Investments fully exited LivaNova in Q3 2020, selling an estimated $7.29M.
  • Pura Vida Investments's ten largest holdings make up 52% of its $1.94B portfolio in Q3 2020.
  • Pura Vida Investments opened 73 new positions and closed 42 in Q3 2020.
  • Pura Vida Investments's portfolio value rose 87% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.